Neuroendocrine and immune contributors to fatigue.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMC 2933136)

Published in PM R on May 01, 2010

Authors

Marni N Silverman1, Christine M Heim, Urs M Nater, Andrea H Marques, Esther M Sternberg

Author Affiliations

1: Section on Neuroendocrine Immunology and Behavior, National Institute of Mental Health, National Institutes of Health, Rockville, MD(dagger).

Articles citing this

Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci (2012) 1.67

Biomarkers for chronic fatigue. Brain Behav Immun (2012) 1.13

Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus (2014) 0.96

Relationship between autonomic cardiovascular control, case definition, clinical symptoms, and functional disability in adolescent chronic fatigue syndrome: an exploratory study. Biopsychosoc Med (2013) 0.84

Adolescent chronic fatigue syndrome; a follow-up study displays concurrent improvement of circulatory abnormalities and clinical symptoms. Biopsychosoc Med (2012) 0.82

Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing mice. Biol Res Nurs (2014) 0.79

IL-1β reactivity and the development of severe fatigue after military deployment: a longitudinal study. J Neuroinflammation (2012) 0.79

In vivo β-adrenergic receptor responsiveness: ethnic differences in the relationship with symptoms of depression and fatigue. Int J Behav Med (2014) 0.77

Fatigue-induced Orosomucoid 1 Acts on C-C Chemokine Receptor Type 5 to Enhance Muscle Endurance. Sci Rep (2016) 0.76

Targeting fatigue in stroke patients. ISRN Neurol (2011) 0.76

Assessing the prevalence of autoimmune, endocrine, gynecologic, and psychiatric comorbidities in an ethnically diverse cohort of female fibromyalgia patients: does the time from hysterectomy provide a clue? J Pain Res (2015) 0.75

Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms. Front Immunol (2017) 0.75

Topical Review: The Emerging Field of Epigenetics: Informing Models of Pediatric Trauma and Physical Health. J Pediatr Psychol (2015) 0.75

From good health to illness with post-infectious fatigue syndrome: a qualitative study of adults' experiences of the illness trajectory. BMC Fam Pract (2017) 0.75

Central fatigue in multiple sclerosis: a review of the literature. J Spinal Cord Med (2016) 0.75

Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial. BMC Psychiatry (2015) 0.75

Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome. Genet Epigenet (2013) 0.75

Muscle fatigue: general understanding and treatment. Exp Mol Med (2017) 0.75

Effect of voluntary repetitive long-lasting muscle contraction activity on the BOLD signal as assessed by optimal hemodynamic response function. MAGMA (2013) 0.75

Articles cited by this

(truncated to the top 100)

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24

From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90

Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49

Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest (2007) 5.55

The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40

Stress and disorders of the stress system. Nat Rev Endocrinol (2009) 4.61

The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology (2000) 4.59

Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol (2006) 4.05

The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA (1995) 3.93

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry (2003) 3.68

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33

A new view on hypocortisolism. Psychoneuroendocrinology (2005) 3.30

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol (2008) 3.30

Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology (2009) 3.26

The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev (1997) 3.23

Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet (1995) 3.02

The awakening cortisol response: methodological issues and significance. Stress (2004) 2.88

Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry (2004) 2.83

Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry (2008) 2.82

Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun (2007) 2.66

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48

Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol (2008) 2.38

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab (1991) 2.23

Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation (2009) 2.17

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis (2008) 2.13

Beyond heart rate variability: vagal regulation of allostatic systems. Ann N Y Acad Sci (2006) 1.96

Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun (2008) 1.78

Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci (2000) 1.71

Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr (2002) 1.70

Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. J Psychosom Res (2006) 1.67

Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol (2005) 1.63

Principles of saliva secretion. Ann N Y Acad Sci (1993) 1.59

Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation (1998) 1.57

High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum (1997) 1.53

The neuroendocrinology of chronic fatigue syndrome. Endocr Rev (2003) 1.52

High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol (2004) 1.51

A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res (2003) 1.48

Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med (2005) 1.47

Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res (2000) 1.46

Immunological aspects of chronic fatigue syndrome. Autoimmun Rev (2008) 1.42

Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun (2007) 1.42

Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry (2004) 1.41

Fatigue in chronic disease. Clin Sci (Lond) (2000) 1.38

The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol (2004) 1.38

The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol (2000) 1.36

The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab (2004) 1.35

Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry (2009) 1.32

Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr Rheumatol Rep (2007) 1.28

Central fatigue: the serotonin hypothesis and beyond. Sports Med (2006) 1.26

Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study. Biol Psychiatry (2008) 1.26

Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann N Y Acad Sci (1995) 1.23

The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci (2000) 1.22

Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med (1997) 1.21

Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol (2001) 1.18

Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17

Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci (2007) 1.15

Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. J Clin Endocrinol Metab (2007) 1.14

The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) (1998) 1.13

Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci (Lond) (1998) 1.12

Vagal tone and the inflammatory reflex. Cleve Clin J Med (2009) 1.11

Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst (1999) 1.11

Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci (2001) 1.07

Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06

Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system? Med Hypotheses (2009) 1.05

Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study. J Immunol Methods (2006) 1.04

Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms. Curr Opin Psychiatry (2009) 1.02

Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr (1999) 0.99

Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J Affect Disord (2005) 0.98

Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther (2004) 0.97

Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome. Psychol Med (2007) 0.97

Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med (Berl) (2004) 0.93

Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol (1999) 0.93

Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance. Neuroimmunomodulation (2008) 0.92

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab (2001) 0.92

Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology (2007) 0.92

Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord (1998) 0.91

Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allergy Clin Immunol (1998) 0.91

Sympathetic overactivity in subjects complaining of unexplained fatigue. Clin Sci (Lond) (1994) 0.90

Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry (2001) 0.90

Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med (1998) 0.90

Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors. J Investig Med (2001) 0.89

Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology (1998) 0.89

Disturbed adrenal function in adolescents with chronic fatigue syndrome. J Pediatr Endocrinol Metab (2005) 0.88

Circulating lymphokine levels in the chronic fatigue syndrome. J Infect Dis (1989) 0.87

Catecholamines in human saliva. Life Sci (2001) 0.86

Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress (2003) 0.86

Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol (1997) 0.85

Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome. Clin Auton Res (1998) 0.85

Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med (2002) 0.85

Autonomic function and serum erythropoietin levels in chronic fatigue syndrome. J Psychosom Res (2004) 0.85

Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. Clin Auton Res (1996) 0.85

A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord (1998) 0.84

Cardiovascular response to upright tilt in fibromyalgia differs from that in chronic fatigue syndrome. J Rheumatol (2001) 0.84

Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones. BMC Musculoskelet Disord (2004) 0.84

Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. Arch Intern Med (2000) 0.84

Adrenocortical activity and some clinical findings in acute and chronic fatigue. J Psychosom Res (1981) 0.83

Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology (1998) 0.82

Core body temperature is normal in chronic fatigue syndrome. Biol Psychiatry (1998) 0.82

An extended concept of altered self: chronic fatigue and post-infection syndromes. Psychoneuroendocrinology (2007) 0.81

Articles by these authors

Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60

Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71

Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65

Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33

Neuroendocrine regulation of immunity. Annu Rev Immunol (2001) 3.11

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci U S A (2003) 2.56

Determinants of salivary alpha-amylase in humans and methodological considerations. Psychoneuroendocrinology (2009) 1.97

Caregiving burden, stress, and health effects among family caregivers of adult cancer patients. JAMA (2012) 1.85

Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorder. Brain Behav Immun (2011) 1.84

Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity? Ann N Y Acad Sci (2004) 1.80

Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol (2002) 1.73

Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol (2013) 1.70

Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci (2012) 1.67

A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun (2010) 1.61

Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products. J Endocrinol (2004) 1.47

Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther (2003) 1.40

Low bone mass in premenopausal women with depression. Arch Intern Med (2007) 1.38

The Lourdes medical cures revisited. J Hist Med Allied Sci (2012) 1.38

Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Arch Gen Psychiatry (2009) 1.32

Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER study. Biol Psychiatry (2008) 1.26

Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion. Int Immunol (2007) 1.24

Neuroendocrine factors alter host defense by modulating immune function. Cell Immunol (2008) 1.19

Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom Med (2005) 1.18

Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc Natl Acad Sci U S A (2003) 1.16

Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci (2007) 1.15

Association of childhood trauma with cognitive function in healthy adults: a pilot study. BMC Neurol (2010) 1.13

Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann N Y Acad Sci (2009) 1.12

The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol (2008) 1.09

Neural-immune interactions in health and disease. Ann N Y Acad Sci (2002) 1.09

Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin. Infect Immun (2005) 1.06

The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol (2005) 1.05

Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study. J Immunol Methods (2006) 1.04

Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav Immun (2010) 1.02

Prolonged salivary cortisol recovery in second-trimester pregnant women and attenuated salivary alpha-amylase responses to psychosocial stress in human pregnancy. J Clin Endocrinol Metab (2006) 1.01

Stress management interventions in the workplace improve stress reactivity: a randomised controlled trial. Occup Environ Med (2010) 1.00

Sex-specific effects of intranasal oxytocin on autonomic nervous system and emotional responses to couple conflict. Soc Cogn Affect Neurosci (2012) 0.98

Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry (2014) 0.95

The effect of music on the human stress response. PLoS One (2013) 0.93

Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance. Neuroimmunomodulation (2008) 0.92

Inflammatory genes and neural activity: involvement of immune genes in synaptic function and behavior. Front Biosci (2005) 0.92

Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J Rheumatol (2002) 0.92

Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J Neuroimmunol (2004) 0.91

Evaluation of steroid hormone receptor protein expression in intact cells using flow cytometry. Nucl Recept Signal (2007) 0.90

Prevalence, overlap, and predictors of functional somatic syndromes in a student sample. Int J Behav Med (2013) 0.90

Inhibitory effects of progesterone differ in dendritic cells from female and male rodents. Gend Med (2008) 0.88

Inflammatory aspects of depression. Inflamm Allergy Drug Targets (2008) 0.87

Effects of Music Listening on Pre-treatment Anxiety and Stress Levels in a Dental Hygiene Recall Population. Int J Behav Med (2015) 0.87

Inflammation and cardiorespiratory control: the role of the vagus nerve. Respir Physiol Neurobiol (2011) 0.86

Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia. Psychosom Med (2009) 0.86

Effects of the physical work environment on physiological measures of stress. Eur J Cardiovasc Prev Rehabil (2010) 0.86

High and low unstimulated salivary cortisol levels correspond to different symptoms of functional gastrointestinal disorders. J Psychosom Res (2005) 0.86

Differential induction of interleukin-I beta mRNA in the brain parenchyma of Lewis and Fischer rats after peripheral injection of lipopolysaccharides. J Neuroimmunol (2003) 0.86

Psychological stress and self-reported functional gastrointestinal disorders. J Nerv Ment Dis (2010) 0.85

Treatment of posttraumatic stress disorder with phenytoin: an open-label pilot study. J Clin Psychiatry (2004) 0.85

Evaluation of stress systems by applying noninvasive methodologies: measurements of neuroimmune biomarkers in the sweat, heart rate variability and salivary cortisol. Neuroimmunomodulation (2010) 0.84

Go no-go performance under psychosocial stress: beneficial effects of implementation intentions. Neurobiol Learn Mem (2008) 0.84

Anthrax lethal toxin represses glucocorticoid receptor (GR) transactivation by inhibiting GR-DNA binding in vivo. Mol Cell Endocrinol (2005) 0.84

[A paradigm for understanding and treating psychiatric illness]. Rev Bras Psiquiatr (2007) 0.83

An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome. BMC Med (2009) 0.83

Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study. J Psychopharmacol (2005) 0.83

Self-perceived stress reactivity is an indicator of psychosocial impairment at the workplace. BMC Public Health (2010) 0.83

Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. J Neuroimmunol (2002) 0.82

Gynecological history in chronic fatigue syndrome: a population-based case-control study. J Womens Health (Larchmt) (2010) 0.81

Emotion regulation through listening to music in everyday situations. Cogn Emot (2011) 0.81

Neural concomitants of immunity--focus on the vagus nerve. Neuroimage (2009) 0.81

The glucocorticoid receptor: a revisited target for toxins. Toxins (Basel) (2010) 0.81

The neuroendocrine system and rheumatoid arthritis: insights from anti-tumor necrosis factor-alpha therapy. J Rheumatol (2007) 0.80

Maternal behavior in F344/N and LEW/N rats. Effects on carrageenan-induced inflammatory reactivity and body weight. Physiol Behav (2002) 0.79

Tissue expression of steroid hormone receptors is associated with differential immune responsiveness. Brain Behav Immun (2010) 0.79

Heart rate variability changes in pregnant and non-pregnant women during standardized psychosocial stress. Acta Obstet Gynecol Scand (2009) 0.79

Norepinephrine and epinephrine responses to physiological and pharmacological stimulation in chronic fatigue syndrome. Biol Psychol (2013) 0.79

Flow cytometry as a tool for measurement of steroid hormone receptor protein expression in leukocytes. Methods Mol Biol (2009) 0.78

Lewis hypothalamic cells constitutively and upon stimulation express higher levels of mRNA for pro-inflammatory cytokines and related molecules: comparison with inflammatory resistant Fischer rat hypothalamic cells. J Neuroimmunol (2003) 0.78

Assessing cortisol reactivity to a linguistic task as a marker of stress in individuals with left-hemisphere stroke and aphasia. J Speech Lang Hear Res (2007) 0.78

The large clostridial toxins from Clostridium sordellii and C. difficile repress glucocorticoid receptor activity. Infect Immun (2007) 0.78

Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder. Arq Neuropsiquiatr (2012) 0.78

Mental illness in metropolitan, urban and rural Georgia populations. BMC Public Health (2013) 0.78

Novel repression of the glucocorticoid receptor by anthrax lethal toxin. Ann N Y Acad Sci (2004) 0.77

Development of a sensitive microarray immunoassay for the quantitative analysis of neuropeptide Y. Anal Chem (2012) 0.77

Increased pro-thyrotropin-releasing hormone transcription in hypophysiotropic neurons of Lewis rats. J Neuroimmunol (2004) 0.77

IL-1 beta-mediated neuropeptide and immediate early gene mRNA induction is defective in Lewis hypothalamic cell cultures. J Neuroimmunol (2004) 0.76

Caffeine administration does not alter salivary α-amylase activity in young male daily caffeine consumers. BMC Res Notes (2014) 0.76

Bacillus anthracis lethal toxin represses MMTV promoter activity through transcription factors. J Mol Biol (2009) 0.76

Matching therapy to body rhythms: an endocrine approach to treating rheumatoid arthritis. J Rheumatol (2010) 0.76

Keyes et Al. Respond to "hormonal contraception and mood". Am J Epidemiol (2013) 0.76

Coping styles in chronic fatigue syndrome: findings from a population-based study. Psychother Psychosom (2012) 0.76

Functional somatic syndromes: asking about exclusionary medical conditions results in decreased prevalence and overlap rates. BMC Public Health (2014) 0.75

Walter B. Cannon and " 'Voodoo' Death": a perspective from 60 years on. Am J Public Health (2002) 0.75

Oxytocin and pair bonding: on possible influences during the life course. Biol Psychiatry (2012) 0.75

Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. J Affect Disord (2012) 0.75

Foreword. Ann N Y Acad Sci (2009) 0.75

Differential expression of class I MHC mRNA in the hypothalamus of Lewis and Fischer rats. J Neuroimmunol (2003) 0.75

Psychosocial Stress-Induced Analgesia: An Examination of Effects on Heat Pain Threshold and Tolerance and of Neuroendocrine Mediation. Neuropsychobiology (2017) 0.75

How We Experience Being Alone: Age Differences in Affective and Biological Correlates of Momentary Solitude. Gerontology (2016) 0.75

Preface. Neuroimmunomodulation: a Kuhnian model of evolution of a scientific field. Ann N Y Acad Sci (2003) 0.75

Guest editorial: functional somatic syndromes. Int J Behav Med (2013) 0.75

Rasch scalability of the somatosensory amplification scale: a mixture distribution approach. J Psychosom Res (2013) 0.75